EP08.02-082 Treatment Patterns and Outcomes of First-line Osimertinib-treated Advanced EGFR Mutated NSCLC Patients: A Real-world Study

Autor: Lee, J.Y., Mai, V., Garcia, M., Cheng, S., Khan, K., Balaratnam, K., Thakral, A., Brown, M.C., Zhan, L., Corke, L., Leighl, N., Shepherd, F.A., Bradbury, P., Sacher, A., Liu, G.
Zdroj: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S440-S440
Databáze: ScienceDirect